Drugs / Loestrin 1/20
last change Jan 2021 re-read 2 minutes ago

Loestrin 1/20

Developed for
polycystic ovary syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00704912 Comparator Sep 2008 → Mar 2014 polycystic ovary syndrome Milton S. Hershey Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Loestrin 1/20 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00704912
Route Oral “continuous oral contraceptive pills” PMID 32968804 Jan 2021